Clinical Trial Update: Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial compared the pharmacodynamics and pharmacokinetics of Biphasic Insulin Aspart 50 versus Biphasic Insulin Aspart 70 in adults with Type 2 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 50 (insulin aspart, biphasic 50/50)
• Biphasic insulin aspart 70 (insulin aspart, biphasic 70/30)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED